Form 4 for MDT Medtronic
Accepted 2025-07-30 00:00:00 ET · period of report 2025-07-28 · accession 0001613103-25-000117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-30 | 2025-07-28 | MDT | Wall Brett A. | EVP, Pres Neuroscience | A - Grant | $0.00 | +9,786 | 51.3K | +24% | $0 |
| DM | 2025-07-30 | 2025-07-28 | MDT | Wall Brett A. | EVP, Pres Neuroscience | A - Grant | $0.00 | +93.5K | 24.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-07-28 | A | A | 9,786 | $0.00 | 51,282 | D | — | — | (F1) Represents restricted stock units that vest 100% on the third anniversary of the date of grant. (F2) Includes 517 shares acquired through dividend reinvestment since the last report filed by the reporting person. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-07-28 | A | A | 69,005 | $0.00 | 69,005 | D | $91.97 · — to 2035-07-28 | 69,005 Ordinary Shares | (F6) These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. |
| 3 | Derivative | Performance Share Units | 2025-07-28 | A | A | 24,465 | $0.00 | 24,465 | D | — · — to — | 24,465 Performance Share Unit | (F3) Each performance share unit represents a contingent right to receive one share of Medtronic common stock. (F4) Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. |